Skip to main content

Symptoms Complexes in Urology

  • Chapter
  • First Online:
Urologic Principles and Practice

Part of the book series: Springer Specialist Surgery Series ((SPECIALIST))

Abstract

The overactive bladder, underactive bladder and bladder pain syndrome commonly present with characteristic groups of symptoms, and are recognized as the common symptom complexes in urology. Each is highly bothersome to the patient whilst little is understood about their aetiopathogeneses and each lacks a simple and effective cure. This chapter outlines the principles which underpin our current understanding of these symptom complexes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Turner-Warwick R, Whiteside CG. Clinical urodynamics. Urol Clin North Am. 1979;6:1.

    Google Scholar 

  2. Abrams P. New words for old: lower urinary tract symptoms for “prostatism”. BMJ. 1994;308(6934):929–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Abrams P, Wein AJ. Introduction to the overactive bladder: from basic science to clinical management. Urology. 1997;50(6):1–3.

    Article  Google Scholar 

  4. Wein A. Symptom-based diagnosis of overactive bladder: an overview. Can Urol Assoc J. 2011;5(Suppl 2):S135–6.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Wein A. Classification of neurogenic voiding dysfunction. J Urol. 1981;125(5):605–9.

    Article  CAS  PubMed  Google Scholar 

  6. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78.

    Article  PubMed  Google Scholar 

  7. Osman NI, Chapple CR. Overactive bladder syndrome: current pathophysiological concepts and therapeutic approaches. Arab J Urol. 2013;11(4):313–8.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Lee UJ, Scott V, Rashid R, Behniwal A, Wein A, Maliski S, et al. Defining and managing overactive bladder: disagreement among the experts. Urology. 2013;81(2):257–62.

    Article  PubMed  Google Scholar 

  9. Al-Ghazo MA, Ghalayini IF, Al-Azab R, Hani OB, Matani YS, Haddad Y. Urodynamic detrusor overactivity in patients with overactive bladder symptoms. Int Neurourol J. 2011;15(1):48–54.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Digesu GA, Khullar V, Cardozo L, Salvatore S. Overactive bladder symptoms: do we need urodynamics? Neurourol Urodyn. 2003;22(2):105–8.

    Article  PubMed  Google Scholar 

  11. Giarenis I, Mastoroudes H, Srikrishna S, Robinson D, Cardozo L. Is there a difference between women with or without detrusor overactivity complaining of symptoms of overactive bladder? BJU Int. 2013;112(4):501–7.

    Article  PubMed  Google Scholar 

  12. Hashim H, Abrams P. Is the bladder a reliable witness for predicting detrusor overactivity? J Urol. 2006;175(1):191–4.

    Article  CAS  PubMed  Google Scholar 

  13. Hyman MJ, Groutz A, Blaivas JG. Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings. J Urol. 2001;166(2):550–2; discussion 553

    Article  CAS  PubMed  Google Scholar 

  14. Jeong SJ, Lee SC, Jeong CW, Hong SK, Byun S-S, Lee SE. Clinical and urodynamic differences among women with overactive bladder according to the presence of detrusor overactivity. Int Urogynecol J. 2013;24(2):255–61.

    Article  PubMed  Google Scholar 

  15. Sekido N, Hinotsu S, Kawai K, Shimazui T, Akaza H. How many uncomplicated male and female overactive bladder patients reveal detrusor overactivity during urodynamic study? Int J Urol. 2006;13(10):1276–9.

    Article  PubMed  Google Scholar 

  16. Abrams P, Blaivas JG, Stanton SL, Andersen JT. The standardisation of terminology of lower urinary tract function. The International Continence Society Committee on Standardisation of Terminology. Scand J Urol Nephrol Suppl. 1988;114:5–19.

    CAS  PubMed  Google Scholar 

  17. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306–14; discussion 1314–5

    Article  PubMed  Google Scholar 

  18. Irwin DE, Abrams P, Milsom I, Kopp Z, Reilly K, EPIC Study Group. Understanding the elements of overactive bladder: questions raised by the EPIC study. BJU Int. 2008;101(11):1381–7.

    Article  PubMed  Google Scholar 

  19. Stewart WF, Van Rooyen JB, Cundiff GW, Abrams P, Herzog AR, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–36.

    Article  CAS  PubMed  Google Scholar 

  20. Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology. 2011;77(5):1081–7.

    Article  PubMed  Google Scholar 

  21. Eapen RS, Radomski SB. Review of the epidemiology of overactive bladder. Res Rep Urol. 2016;8:71–6.

    PubMed  PubMed Central  Google Scholar 

  22. Brading AF, Turner WH. The unstable bladder: towards a common mechanism. Br J Urol. 1994;73(1):3–8.

    Article  CAS  PubMed  Google Scholar 

  23. Neuhaus J, Pfeiffer F, Wolburg H, Horn L-C, Dorschner W. Alterations in connexin expression in the bladder of patients with urge symptoms. BJU Int. 2005;96(4):670–6.

    Article  CAS  PubMed  Google Scholar 

  24. Drake M, Mills I, Gillespie J. Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function. Lancet. 2001;358(9279):401–3.

    Article  CAS  PubMed  Google Scholar 

  25. Andersson K-E. Bladder activation: afferent mechanisms. Urology. 2002;59(5):43–50.

    Article  PubMed  Google Scholar 

  26. Yoshida M, Masunaga K, Nagata T, Yono M, Homma Y. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: pathophysiology and pharmacotherapy of overactive bladder. J Pharmacol Sci. 2010;112(2):128–34.

    Article  CAS  PubMed  Google Scholar 

  27. de Groat WC. A neurologic basis for the overactive bladder. Urology. 1997;50(6):36–52.

    Article  CAS  PubMed  Google Scholar 

  28. Palmer CJ, Choi JM. Pathophysiology of overactive bladder: current understanding. Curr Bladder Dysfunct Rep. 2017;12(1):74–9.

    Article  Google Scholar 

  29. Osman NI, Esperto F, Chapple CR. Detrusor underactivity and the underactive bladder: a systematic review of preclinical and clinical studies. Eur Urol. 2018;74(5):633–43.

    Article  PubMed  Google Scholar 

  30. Chapple CR, Osman NI, Birder L, van Koeveringe GA, Oelke M, Nitti VW, et al. The underactive bladder: a new clinical concept? Eur Urol. 2015;68(3):351–3.

    Article  PubMed  Google Scholar 

  31. Smith PP. Pathophysiology of the underactive bladder: evolving new concepts. Curr Bladder Dysfunct Rep. 2017;12(1):35–41.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Osman NI, Chapple CR, Abrams P, Dmochowski R, Haab F, Nitti V, et al. Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, and diagnosis. Eur Urol. 2014;65(2):389–98.

    Article  PubMed  Google Scholar 

  33. Valente S, DuBeau C, Chancellor D, Okonski J, Vereecke A, Doo F, et al. Epidemiology and demographics of the underactive bladder: a cross-sectional survey. Int Urol Nephrol. 2014;46(1):7–10.

    Article  Google Scholar 

  34. Gammie A, Kaper M, Dorrepaal C, Kos T, Abrams P. Signs and symptoms of detrusor underactivity: an analysis of clinical presentation and urodynamic tests from a large group of patients undergoing pressure flow studies. Eur Urol. 2016;69(2):361–9.

    Article  PubMed  Google Scholar 

  35. Cho KJ, Koh JS, Choi J, Kim JC. Changes in adenosine triphosphate and nitric oxide in the urothelium of patients with benign prostatic hyperplasia and detrusor underactivity. J Urol. 2017;198(6):1392–6.

    Article  CAS  PubMed  Google Scholar 

  36. Jiang Y-H, Kuo H-C. Urothelial barrier deficits, suburothelial inflammation and altered sensory protein expression in detrusor underactivity. J Urol. 2017;197(1):197–203.

    Article  PubMed  Google Scholar 

  37. Smith PP. Aging and the underactive detrusor: a failure of activity or activation? Neurourol Urodyn. 2010;29(3):408–12.

    PubMed  Google Scholar 

  38. Shafik A, Shafik AA, El-Sibai O, Ahmed I. Role of positive urethrovesical feedback in vesical evacuation. The concept of a second micturition reflex: the urethrovesical reflex. World J Urol. 2003;21(3):167–70.

    Article  PubMed  Google Scholar 

  39. Gustafson KJ, Creasey GH, Grill WM. A urethral afferent mediated excitatory bladder reflex exists in humans. Neurosci Lett. 2004;360(1–2):9–12.

    Article  CAS  PubMed  Google Scholar 

  40. Coelho A, Oliveira R, Cavaleiro H, Cruz CD, Cruz F. Evidence for an urethro-vesical crosstalk mediated by serotonin. Neurourol Urodyn. 2018;37(8):2389–97.

    Article  CAS  PubMed  Google Scholar 

  41. Azadzoi KM, Radisavljevic ZM, Golabek T, Yalla SV, Siroky MB. Oxidative modification of mitochondrial integrity and nerve fiber density in the ischemic overactive bladder. J Urol. 2010;183(1):362–9.

    Article  PubMed  Google Scholar 

  42. Zhao Z, Azad R, Yang J-H, Siroky MB, Azadzoi KM. Progressive changes in detrusor function and micturition patterns with chroinc bladder ischemia. Investig Clin Urol. 2016;57(4):249–59.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28–29, 1987. J Urol. 1988;140(1):203–6.

    Article  CAS  PubMed  Google Scholar 

  44. Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L. The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol. 1999;161(2):553–7.

    Article  CAS  PubMed  Google Scholar 

  45. Hanno P, Dmochowski R. Status of international consensus on interstitial cystitis/bladder pain syndrome/painful bladder syndrome: 2008 snapshot. Neurourol Urodyn. 2009;28(4):274–86.

    Article  PubMed  Google Scholar 

  46. Hanno PM, Burks DA, Clemens JQ, Dmochowski RR, Erickson D, Fitzgerald MP, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2011;185(6):2162–70.

    Article  PubMed  Google Scholar 

  47. McLennan MT. Interstitial cystitis: epidemiology, pathophysiology, and clinical presentation. Obstet Gynecol Clin North Am. 2014;41(3):385–95.

    Article  PubMed  Google Scholar 

  48. Davis NF, Brady CM, Creagh T. Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options. Eur J Obstet Gynecol Reprod Biol. 2014;175:30–7.

    Article  CAS  PubMed  Google Scholar 

  49. Berry SH, Elliott MN, Suttorp M, Bogart LM, Stoto MA, Eggers P, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol. 2011;186(2):540–4.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Clemens JQ, Meenan RT, Rosetti MCO, Gao SY, Calhoun EA. Prevalence and incidence of interstitial cystitis in a managed care population. J Urol. 2005;173(1):98–102; discussion 102

    Article  PubMed  Google Scholar 

  51. Lindahl U, Couchman J, Kimata K, Esko JD. Proteoglycans and sulfated glycosaminoglycans. In: Varki A, Cummings RD, Esko JD, Stanley P, Hart GW, Aebi M, et al., editors. Essentials of glycobiology [Internet]. 3rd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2015 [cited 2018 Dec 20]. http://www.ncbi.nlm.nih.gov/books/NBK453033/

  52. Daniels AM, Schulte AR, Herndon CM. Interstitial cystitis: an update on the disease process and treatment. J Pain Palliat Care Pharmacother. 2018;32(1):49–58.

    Article  PubMed  Google Scholar 

  53. Patnaik SS, Laganà AS, Vitale SG, Butticè S, Noventa M, Gizzo S, et al. Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome. Arch Gynecol Obstet. 2017;295(6):1341–59.

    Article  CAS  PubMed  Google Scholar 

  54. Nausch B, Heppner TJ, Nelson MT. Nerve-released acetylcholine contracts urinary bladder smooth muscle by inducing action potentials independently of IP3-mediated calcium release. Am J Physiol Regul Integr Comp Physiol. 2010;299(3):R878–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Fernandes VS, Hernández M. The role of nitric oxide and hydrogen sulfide in urinary tract function. Basic Clin Pharmacol Toxicol. 2016;119 Suppl 3:34–41.

    Article  CAS  PubMed  Google Scholar 

  56. Munoz A, Smith CP, Boone TB, Somogyi GT. Overactive and underactive bladder dysfunction is reflected by alterations in urothelial ATP and NO release. Neurochem Int. 2011;58(3):295–300.

    Article  CAS  PubMed  Google Scholar 

  57. Homma Y, Ueda T, Tomoe H, Lin AT, Kuo H-C, Lee M-H, et al. Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015. Int J Urol. 2016;23(7):542–9.

    Article  PubMed  Google Scholar 

  58. Buffington CA, Pacak K. Increased plasma norepinephrine concentration in cats with interstitial cystitis. J Urol. 2001;165(6 Pt 1):2051–4.

    Article  CAS  PubMed  Google Scholar 

  59. Stein PC, Torri A, Parsons CL. Elevated urinary norepinephrine in interstitial cystitis. Urology. 1999;53(6):1140–3.

    Article  CAS  PubMed  Google Scholar 

  60. Reche Júnior A, Buffington CA. Increased tyrosine hydroxylase immunoreactivity in the locus coeruleus of cats with interstitial cystitis. J Urol. 1998;159(3):1045–8.

    Article  PubMed  Google Scholar 

  61. Westropp JL, Welk KA, Buffington CAT. Small adrenal glands in cats with feline interstitial cystitis. J Urol. 2003;170(6):2494–7.

    Article  PubMed  Google Scholar 

  62. Dimitrakov J, Tchitalov J, Zlatanov T, Dikov D, Rawadi G. Corticotropin-releasing hormone perturbations in interstitial cystitis patients: evidence for abnormal sympathetic activity. Urology. 2001;57:128.

    Article  CAS  PubMed  Google Scholar 

  63. Liu B, Yang F, Zhan H, Feng Z, Zhang Z, Li W, et al. Increased severity of inflammation correlates with elevated expression of TRPV1 nerve fibers and nerve growth factor on interstitial cystitis/bladder pain syndrome. Urol Int. 2014;92(2):202–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wilson, K.J., Osman, N.I. (2020). Symptoms Complexes in Urology. In: Chapple, C., Steers, W., Evans, C. (eds) Urologic Principles and Practice. Springer Specialist Surgery Series. Springer, Cham. https://doi.org/10.1007/978-3-030-28599-9_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-28599-9_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-28598-2

  • Online ISBN: 978-3-030-28599-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics